Gritstone and gilead case study
Transaction Case Studies SELL-SIDE ENGAGEMENT FOR GRITSTONE LEADING TO A PARTNERSHIP WITH GILEAD FOR $60M UPFRONT AND $725M IN ADDITIONAL […]
Uncategorized
Uncategorized
c4 case study
Transaction Case Studies RAPID FINANCING PROCESS LED TO OVERSUBSCRIBED CROSSOVER FINANCING Situation Assessment C4 Therapeutics is a private biotech with
Uncategorized
c4 ipo case study
Transaction Case Studies IPO Advisory assignment helping raise $210M in a NASDAQ IPO Situation Assessment Following the completion of a
Uncategorized
Nevakar and zhaoke case study
Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private
Uncategorized
Twi
Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company
News
Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021
LOCUST WALK NEWS Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1,
News
Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option PHILADELPHIA